论文部分内容阅读
中国人民解放军第二军医大学第三附属医院(东方肝胆外科医院,东方肝胆外科研究所),是在我国肝胆外科开拓者、著名肝胆外科专家、中国科学院院士吴孟超教授领导下,从1958年成立肝胆外科三人小组开始,经过40多年的自力更生、艰苦奋斗、奋发图强、勇攀高峰,由一个小组发展到集医、教、研为一体的院、所合一国内惟一的专科医院,已成为国家重点学科,国家级继续医学教育基地,全军肝胆外科专科中心,全军肝胆外科研究所,全军重点实验室,军队“重中之重”建设学科,上海市医学领先专业重点学科,上海市临床医学中心。1993年5月,原中共中央总书记、国家主席、中央军委主席江泽民亲笔题写院名、所名。1996年12月被总后勤部批准为“三级甲等”专科医院,拥有660张床位和先进的仪器设备。东方肝胆外科医院长期坚持医、教、研相结合,在原发性肝癌的早期诊断和治疗,中晚期肝癌的综合治疗,原发性肝癌术后抗复发治疗,肿瘤的免疫治疗、介入治疗,复杂胆道疾病的手术治疗,肝胆疾病的内窥镜治疗,以及肝移植等方面均居国内外先进水平。不仅采用传统的外科手术治疗方法,还采取了微波方法、射频方法、氩氦刀方法、激光光敏技术、肝内肿瘤酒精注射疗法和经股动脉至肝动脉插管加栓塞疗法等。现年门诊量7万多人次,年收治住院病人11000多人次。至2004年12月止,吴孟超率领同事们已成功实施肝脏切除术近17000例,积累了国际上最大宗的肝癌病例库和标本库,手术成功率达98.5%,术后5年总生存率达48.6%,小肝癌术后5年生存率达79.8%,术后生存时间最长的已达40年,病人至今健在。肝癌切除例数、切除率、生存率等指标均处于国际领先水平。1996年成功施行肝移植5例,最小的病人年仅9岁。除1例术后半年,因原有的肝炎急性发作导致暴发性肝炎死亡外,其余4
The Third Affiliated Hospital of the Second Military Medical University of Chinese PLA (Eastern Hepatobiliary Surgery Hospital, Institute of Oriental Hepatobiliary Surgery) is a pioneer of hepatobiliary surgery in China, a famous hepatobiliary surgery specialist, under the leadership of Professor Wu Mengchao, Chinese Academy of Sciences, from 1958 to establish hepatobiliary After more than 40 years of self-reliance, hard work, hard work and tremendous growth, the team of three in surgery has developed from a group to a hospital that integrates medicine, teaching and research. The only specialist hospital in the country has become a national priority Discipline, state-level continuing medical education base, the army’s hepatobiliary surgery specialist center, the army’s Institute of Hepatobiliary Surgery, the key laboratories of the army, the military “top priority” construction discipline, Shanghai medical major professional disciplines, Shanghai clinical Medical Center. In May 1993, former General Secretary of the Central Committee of the Communist Party of China, State President and Chairman of the Central Military Commission Jiang Zemin personally wrote the name of the academy and its name. December 1996 was approved by the General Logistics Department as “three A-level” specialist hospitals, with 660 beds and advanced equipment. Eastern Hepatobiliary Surgery Hospital has long insisted on the combination of medicine, teaching and research in the early diagnosis and treatment of primary liver cancer, the comprehensive treatment of advanced liver cancer, anti-recurrence therapy of primary liver cancer after surgery, tumor immunotherapy, interventional therapy, Surgical treatment of complicated biliary tract diseases, endoscopic treatment of hepatobiliary diseases, and liver transplantation both rank the advanced level at home and abroad. Not only the traditional surgical treatment methods, but also taken the microwave method, radio frequency method, argon helium knife method, laser light-sensitive technology, intrahepatic tumor alcohol injection therapy and the femoral artery to hepatic artery embolization and embolization therapy. Outpatient volume of more than 70,000 passengers, received more than 11,000 inpatients. As of December 2004, Wu Mengchao led his colleagues have successfully implemented nearly 17,000 cases of liver resection, the accumulation of the world’s largest case of liver cancer and specimen pool, the success rate of 98.5%, 5-year postoperative survival rate of up to 48.6%, 5-year survival rate of small hepatocellular carcinoma after surgery reached 79.8%, the longest postoperative survival time has reached 40 years, the patient is still alive. The number of resected liver cancer, resection rate, survival rate and other indicators are in the international advanced level. Five cases of liver transplantation were successfully implemented in 1996, the youngest patient was only 9 years old. In addition to one case of six months after surgery, due to the original acute hepatitis attack led to fulminant hepatitis death, the remaining 4